The first Clearside Biomedical trade was made in Q1 2017.
Since then Jim Simons bought shares fourteen more times and sold shares on seventeen occasions. The investor completely sold their stake between Q4 2024 and Q4 2025.
Avg closing price
Price range
Sold -25.2k shares
Q4 2025
Avg closing price
$2.10
Price range
$0.41
-
$4.40
Sold 23.7% shares (-7.86k shares)
Q3 2025
Avg closing price
$2.68
Price range
$0.34
-
$6.39
Sold 10.4% shares (-3.86k shares)
Q2 2025
Avg closing price
$0.83
Price range
$0.74
-
$0.93
Sold 23.2% shares (-11.2k shares)
Q1 2025
Avg closing price
$0.96
Price range
$0.79
-
$1.13
Sold 3.1% shares (-1.54k shares)
Q4 2024
Avg closing price
$1.10
Price range
$0.87
-
$1.58
Increased shares by 27.8% (+10.8k shares)
Q3 2024
Avg closing price
$1.14
Price range
$0.93
-
$1.35
Increased shares by 6.6% (+2.39k shares)
Q2 2024
Avg closing price
$1.29
Price range
$1.08
-
$1.58
Increased shares by 42.1% (+10.8k shares)
Q1 2024
Avg closing price
$1.44
Price range
$1.20
-
$2.02
Increased shares by 40.8% (+7.43k shares)
Q4 2023
Avg closing price
$0.95
Price range
$0.68
-
$1.18
Sold 18.8% shares (-4.23k shares)
Q3 2023
Avg closing price
$1.01
Price range
$0.82
-
$1.27
Sold 26.7% shares (-8.18k shares)
Q2 2023
Avg closing price
$1.15
Price range
$0.97
-
$1.48
Sold 21.8% shares (-8.53k shares)
Q1 2023
Avg closing price
$1.29
Price range
$0.93
-
$1.66
Sold 10.8% shares (-4.74k shares)
Q4 2022
Avg closing price
$1.20
Price range
$1.00
-
$1.49
Sold 18.5% shares (-9.95k shares)
Q3 2022
Avg closing price
$1.46
Price range
$1.08
-
$1.83
Sold 6.6% shares (-3.81k shares)
Q2 2022
Avg closing price
$1.62
Price range
$1.30
-
$2.49
Increased shares by 101.5% (+29k shares)
Q1 2022
Avg closing price
$1.99
Price range
$1.35
-
$2.88
Increased shares by 323.0% (+21.8k shares)
Q4 2021